Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
3.000
-0.100 (-3.23%)
Aug 14, 2025, 11:28 AM - Market open
Compass Therapeutics Employees
Compass Therapeutics had 35 employees as of December 31, 2024. The number of employees increased by 3 or 9.38% compared to the previous year.
Employees
35
Change (1Y)
3
Growth (1Y)
9.38%
Revenue / Employee
n/a
Profits / Employee
-$1,772,171
Market Cap
514.72M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35 | 3 | 9.38% |
| Dec 31, 2023 | 32 | 6 | 23.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | -7 | -22.58% |
| Dec 31, 2020 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CMPX News
- 1 day ago - Compass Therapeutics: Finding Their Way With More Positive Updates In BTC - Seeking Alpha
- 1 day ago - Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering - GlobeNewsWire
- 1 day ago - Compass Therapeutics Announces Proposed Public Offering - GlobeNewsWire
- 3 days ago - Compass Therapeutics Reports 2025 Second Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 days ago - Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025 - GlobeNewsWire
- 2 months ago - Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Compass Therapeutics: A Big Positive Signal For Tovecimig In Biliary Tract Cancers - Seeking Alpha
- 3 months ago - Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update - GlobeNewsWire